Literature DB >> 2560266

The fundamental mechanism of inotropic action of digitalis.

T W Smith.   

Abstract

Evidence from several sources, including electrophysiologic studies and cation flux and content measurements, now allows a reasonably cohesive synthesis of the molecular and cellular events that lead from inhibition of the Na pump by digitalis to the enhancement of the generation of contractile force by cardiac muscle. It is generally agreed that Na pump inhibition, with consequent elevation in [Na+]i and [Ca2+]i, underlies both the therapeutic (positive inotropic) and toxic (arrhythmic) responses of the heart, and accounts for the well-known difficulty in separating therapeutic and toxic clinical effects of digitalis glycosides. In the intact patient or experimental animal, cardiac glycosides also exert effects that are mediated through neural pathways, and these can exert important influences on the integrated response to digitalis administration.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2560266

Source DB:  PubMed          Journal:  Therapie        ISSN: 0040-5957            Impact factor:   2.070


  3 in total

1.  Functional antagonism by a monoclonal antibody to digoxin in a test system of cultured rat heart myocytes.

Authors:  G Wallukat; H U Simon; W D Müller; I Wolf
Journal:  Mol Cell Biochem       Date:  1996 Jul-Aug       Impact factor: 3.396

2.  Digitoxin and a synthetic monosaccharide analog inhibit cell viability in lung cancer cells.

Authors:  Hosam A Elbaz; Todd A Stueckle; Hua-Yu Leo Wang; George A O'Doherty; David T Lowry; Linda M Sargent; Liying Wang; Cerasela Zoica Dinu; Yon Rojanasakul
Journal:  Toxicol Appl Pharmacol       Date:  2011-10-18       Impact factor: 4.219

3.  Transcriptome and Metabolite analysis reveal candidate genes of the cardiac glycoside biosynthetic pathway from Calotropis procera.

Authors:  Akansha Pandey; Vishakha Swarnkar; Tushar Pandey; Piush Srivastava; Sanjeev Kanojiya; Dipak Kumar Mishra; Vineeta Tripathi
Journal:  Sci Rep       Date:  2016-10-05       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.